NasdaqCM:VKTXBiotechs
Viking Therapeutics (VKTX) Stock Looks Above Fair Value Today
Viking Therapeutics has delivered a very large 5 year return for shareholders, yet at around US$33.86 per share today the stock still screens as expensive on Simply Wall St's valuation checks. Recent share price weakness adds another layer, with the broader valuation score not pointing to an obvious bargain despite the long term gains.
Viking Therapeutics has returned about 467% over 5 years, which puts extra focus on whether the current price already reflects a lot of optimism.
Excitement...